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Macrophages by Plant Compounds
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Abstract
Macrophages play an important role in cancer development, as they represent 
almost half of the cells forming the tumor microenvironment. They are called 
tumor-associated macrophages (TAMs) and most of them are alternative activated 
macrophages (M2 polarized), promoting cancer progression, angiogenesis and 
local immunosuppression. Blocking the macrophages recruitment, preventing 
their activation or turning M2 cells toward M1 phenotype (classic activated macro-
phage promoting an efficient immune response) is a modern immunotherapeutic 
approach for fighting cancer. Several studies showed that plant compounds (phe-
nolics, triterpenes, coumarins, etc.) exert antitumor properties, not only by a direct 
toxical effect to malignant cells but also by influencing macrophage phenotypic 
differentiation.
Keywords: macrophage polarization, phenolic compounds, saponins, 
polysaccharides, coumarins, anthraquinones, alkaloids, tumor microenvironment
1. Introduction
Macrophages represent up to 50% of the cells infiltrating into the tumor micro-
environment (TME) and modulation of macrophage polarization is an interesting 
and novel therapeutic approach in preclinical or clinical cancer research.
An increasing number of studies have also shown that tumor-associated mac-
rophages (TAMs) can antagonize, augment or mediate the antitumor effects of 
cytotoxic agents, tumor irradiation, anti-angiogenic/vascular damaging agents and 
checkpoint inhibitors [1].
In the tumor microenvironment, TAMs are one of the major contributors in 
angiogenesis by secreting pro-angiogenic factors, such as vascular endothelial growth 
factor (VEGF), adrenomedullin (ADM), platelet-derived growth factor (PDGF), 
tumor growth factor-beta (TGF-β) and matrix metalloproteinases (MMPs). Also, 
TAMs promote tumor cell invasion and metastasis by modifying the composition of 
extracellular matrix and cell-cell junctions and promoting basal membrane disrup-
tion. It was demonstrated that macrophages facilitate the metastasis by enhancing 
the ability of cancer cells to enter a local blood vessel and also are involved in immu-
nosuppression by inhibiting the T-cell response or by secreting immunosuppressive 
cytokines and proteases such as IL-10, TGF-β, arginase-1 and prostaglandins, which 
inhibit T-cell activation and proliferation [2].
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TAMs often exhibit an array of activation states. In general, they are skewed 
away from the “classically” activated, tumoricidal phenotype (sometimes referred 
to as M1) toward an “alternatively” activated tumor-promoting one (M2) [1]. The 
classically activated M1 macrophages are stimulated by microbial substrates such as 
lipopolysaccharide, Toll-like receptor ligands and cytokines such as IFN-γ. They are 
characterized by secretion of pro-inflammatory cytokines such as interleukins IL-6, 
IL-12, IL-23 and TNF-α and express high levels of major histocompatibility com-
plex class II (MHC-II), CD68, and CD80 and CD86 costimulatory molecules. The 
alternatively activated M2 macrophages are stimulated by IL-4 and IL-13, secrete 
IL-10 and TGF-β and express low levels of MHC-II and feature expression of CD163 
and CD206 [3].
Unfortunately, M2 cells are the most representative cells of the TAM population 
within the tumor promoting genetic instability, local immunosuppression and stem 
cell nurturing [4] and providing essential support for a malignant phenotype [5].
In the early stages of cancers of the lung, colon and stomach, the macrophages 
in the normoxic milieu display an M1 phenotype and are associated with good 
prognosis, but within avascular areas of the tumor, TAMs alter the gene expression 
profile, favoring a protumor M2 phenotype, correlated with a bad prognosis [6]. In 
Table 1 are showed recent conclusions concerning the correlation between TAMs 
and clinical prognostics in several tumor types. In human breast carcinomas, high 
TAM density is also associated with poor prognosis [7]. TAMs in renal cell carci-
noma show a mixed M1/M2 phenotype. CD68 alone has a poor predictive value, 
while low CD11+ and high CD206+ as single variables correlated with reduced 
survival [8]. There is strong evidence for an inverse relationship between TAM 
density and clinical prognosis in solid tumors of the breast, prostate, ovary and 
cervix. Type I and II endometrial carcinomas had significantly higher macrophage 
density in both epithelial and stromal compartments than benign endometrium 
[9]. Type II cancers have nearly twice the TAM density of type 1 cancers and this 
difference may be due to M1 macrophage predominance in the stroma of type II 
cancers [10].
TAMs’ distribution pattern could be an independent prognostic factor for the 
overall survival of gastric cancer patients, invasive front-/stroma-dominant pattern 
having worse outcomes [11]. Studies have shown that the amount of TAMs in tumor 
stroma predicts the size, stage and metastasis of the gastric tumor [12]. In lung 
cancer, M2 subset and TAMs in tumor stroma were associated with worse survival, 
while M1 subset and TAMs in tumor islet were associated with favorable survival of 
lung cancer [13].
While most cancer research has focused upon these changes and most therapeu-
tics are directed against these tumor cells, it is now apparent that the non-malignant 
cells in the microenvironment evolve along with the tumor and provide essential 
support for their malignant phenotype [5]. The knowledge of TAM activation status 
may allow the therapeutic targeting of TAMs, once TAMs’ targeting/modulating 
agents pass clinical trials and become widely available [6, 29]. The role of macro-
phages in tumor progression remains to be fully elucidated, in part due to the con-
trasting roles they play depending on their polarization [30]. Both the systemic and 
local environments play a tumor-initiating role through the generation of persistent 
inflammatory responses to a variety of stimuli [31]. To support this correlative data 
between macrophage-mediated inflammation and cancer induction, genetic abla-
tion of the anti-inflammatory transcription factor STAT3 in macrophages results 
in a chronic inflammatory response in the colon that is sufficient to induce invasive 
adenocarcinoma. However, it is unclear whether macrophages in some inflamma-
tory situations can kill aberrant cells before they become tumorigenic and thus be 
antitumoral [32].
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Cancer type TAMs as prognostic factors Reference
Breast CD68 as a biomarker for TAMs to evaluate the risk is better than CD163 
or CD206 alone; high infiltration of TAMs was significantly associated 
with negative hormone receptor status and malignant phenotype
[14]
Gastric The amount of TAMs in tumor stroma predicts the size, stage and 
metastasis of the gastric tumor
Invasive front-/stroma-dominant pattern having worse outcomes
Although CD68+ TAMs infiltration has the neutral prognostic effects on 
OS, the M1/M2 polarization of TAMs are predicative factors of prognosis 
in gastric cancer patients
[11, 12, 15]
Lung The prognostic value of tumor-infiltrating TAMs in lung cancer is still 
controversial. M2 subset and TAMs in tumor stroma were associated 
with worse survival, while M1 subset and TAMs in tumor islet were 
associated with favorable survival of lung cancer. CD204-positive TAMs 
are the preferable marker for prognostic prediction in NSCLC
Although the density of total CD68+ TAMs is not associated with overall 
survival, the localization and M1/M2 polarization of TAMs are potential 
prognostic predictors of NSCLC
[13, 16, 17]
Cervix Tumor-infiltrating CD204+ M2 macrophages may predict poor 
prognosis in patients with cervical adenocarcinoma
[18]
Ovarian CD163+ TAM infiltration was associated with poor prognosis of ovarian 
cancer and high M1/M2 macrophage ratio in tumor tissues predicted 
better prognosis
[19]
Pancreatic Although TAM populations in tumor stroma are high, marking them 
as a probable prognostic factor, the multiple roles that TAMs play in 
pancreatic cancer progression have not yet been delineated. Additional 
mechanistic insight into the pathways that regulate the differentiation of 
TAMs from monocytes is required
The density of TAMs has an impact on the overall survival of pancreatic 
cancer patients. M2-TAMs can be recognized as a prognostic indicator in 
pancreatic cancer
[20, 21]
Renal CD68 alone has a poor predictive value, while low CD11+ and high 
CD206+ as single variables correlated with reduced survival
[8]
Glioblastoma TAM, accounting for approximately 30% of the GBM bulk cell 
population, may explain, at least in part, the immunosuppressive 
features of GBMs
[22]
Hepatocellular 
carcinoma
The prognostic value of TAMs in patients with hepatocellular carcinoma 
(HCC) is still controversial. TAMs could serve as independent predictive 
indicators and therapeutic targets for HCC. Further trials are needed to 
elucidate the exact relationship and the underlying mechanism
[23]
Melanoma Independent of their intratumoral distribution, the prevalent 
accumulation of M2 TAMs in MM is statistically confirmed to be a poor 
indicator of patients’ outcome
[24]
Non-Hodgkin’s 
lymphoma
High-density CD68+ and CD163+ TAMs, and also high CD163+/CD68+ 
TAMs ratio is significantly correlated with poor overall survival
[25]
Hodgkin’s 
lymphoma
High density of either CD68+ or CD163+ TAMs is a robust predictor of 
adverse outcomes in adult cHL
[26]
Colorectal 
(CRC)
The role of tumor-associated macrophages (TAMs) in predicting the 
prognosis of CRC remains controversial. Still, high-density CD68+ 
macrophage infiltration can be a good prognostic marker
[27]
Squamous cell 
carcinoma of 
the head and 
neck (SCCHN)
CD68+ marker has no prognostic utility in patients with SCCHN; the 
M2-like marker CD163+ predicts poor prognosis
[28]
Table 1. 
TAMs as potential predictive indicators in several tumor types.
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Targeting a single signaling axis that promotes the immunosuppressive and 
protumoral functions of macrophages is inadequate as there are multiple signals 
involved in the communication between tumor cells and TAMs. Identifying and 
inhibiting key driver pathways, which are critical for both cancer cell survival 
and TAM activation, may offer therapeutic advantages as they disrupt the vicious 
positive feedback loop between tumor and TAMs [33]. Prevention of TAM accumu-
lation and reduction of TAM presence by depleting existing TAMs represent novel 
strategies for an indirect cancer therapy specifically aimed at tumor-promoting cells 
within the microenvironment, but the challenge with this approach is to find ways 
for local administration of such drugs to the tumor [30]. Targeting TAM polarity 
toward an M1 phenotype also became a real immunotherapeutical approach in 
cancer, recalling responses from both innate and adaptive immune systems, leading 
to tumor regression [4].
Triple combination of anti-CTLA-4, anti-PD-1 and G47Δ-mIL12 was associated 
with macrophage influx and M1-like polarization in two glioma models [34]. A 
combination of a bivalent ganglioside and β-glucan, a yeast-derived polysaccharide, 
able to differentiate TAMs into an M1 phenotype is currently under investigation 
in a phase I clinical trial of patients with neuroblastoma [35]. Vadimezan, a fused 
tricyclic analog of flavone acetic acid, was found to repolarize macrophages in M1 
phenotype, and it has been the subject of numerous preclinical studies and clinical 
trials [36]. Zoledronic acid, a clinical drug for cancer therapy, has been found to 
inhibit spontaneous mammary carcinogenesis by reverting macrophages from the 
M2 phenotype to the M1 phenotype [37].
2. Herbal compounds in TAM modulation
Research to date suggests that, despite the potency of cytotoxic anticancer agents 
and the high specificity that can be achieved by immunotherapy, neither of these 
two types of treatment is sufficient to eradicate the disease. Moreover, even in stan-
dard chemotherapy, there has been efficiency through the introduction into current 
practice of treatments with combinations of drugs [38]. In general, literature data 
show that the combination of conventional treatment with natural compounds 
exerts an additive effect caused by the alternative activation of signaling pathways 
that induce cell death or increase the activity of the chemotherapeutic agent. The 
involvement of these natural compounds (alone or in combination therapy) in 
the immunobiology of cancer is a branch that has not yet been studied but offers 
major therapeutic opportunities. Herbal compounds have many regulatory effects 
on macrophage polarization, but the specific mechanisms, signaling pathways and 
target genes involved remain incompletely understood [39]. Their effects, according 
to recent research studies, are summarized in Figure 1.
Although natural products have historically been a critical source for therapeutic 
drugs, sometimes natural molecules may suffer from insufficient efficacy, unac-
ceptable pharmacokinetic properties, undesirable toxicity or reduced availability, 
which impedes their direct therapeutic application. Poor availability of some 
natural compounds, despite their pharmacological effects, limits their clinical 
application. In recent years, there has been an increased interest in develop-
ing nanoformulations with increased bioavailability and fewer side effects. For 
instance, TAM-rich tumors, due to their enhanced permeability, demonstrated an 
elevated retention (>700%) of the nanotherapeutic (poly(d,l-lactic-co-glycolic 
acid)-b-poly(ethylene glycol) (PLGA-PEG)), as compared to TAM-deficient 
tumors [29].
5Targeting Tumor-Associated Macrophages by Plant Compounds
DOI: http://dx.doi.org/10.5772/intechopen.92298
2.1 Saponins
Triterpenic compounds, including corosolic acid, tigogenin, timosaponin AIII, 
neoaspidistrin and oleanolic acid, suppress the CD163 expression. Corosolic and 
oleanolic acids change M2 polarization to M1 polarization in human monocyte-
derived macrophages (HMDMs) by suppressing STAT3 and NF-kB activation. The 
effects of these two compounds were exerted not only on macrophages but also on 
glioblastoma cells, suppressing tumor cell proliferation and sensitizing tumor cells 
to anticancer drugs [40, 41].
M2 polarization was switched also by astragaloside IV (AS-IV, 3-O-β-d-
xylopyranosyl-6-O-β-d-glucopyranosyl cycloastragenol), a natural saponin 
extracted from Astragali radix, by modulating the AMPK signaling pathway. In the 
intravenous lung cancer model, AS-IV treatment did not alter the percentage of 
macrophages but did significantly reduce the number of M2 macrophages [42]. In 
another study, G-Rh2, a monomeric compound extracted from Panax ginseng C. A. 
Figure 1. 
Herbal compounds and their main actions on TAMs in cancer progression.
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Mey (ginseng), converts the differentiation of macrophages from M2 to M1 pheno-
type resulting in the decreased levels of MMPs and VEGF. By blocking the PI3K-Akt 
signaling pathway, the compound prevented the metastasis of lung cancer (NSCLC) 
cells [43]. Recently, a novel EV-liked ginseng-derived nanoparticle (GDNP) was 
tested in melanoma, and it altered M2 polarization both in vitro and in vivo, depend-
ing on TLR4 and MyD88 signaling and contributing to an antitumor response [44].
A potential role of celastrol, a pentacyclic triterpenoid in antimetastasis treatment, 
was suggested by Yang et al. [45], which found that this compound suppresses M2-like 
polarization by interfering with STAT6 signaling pathway after stimulation with IL-13. 
An active role in decreasing macrophage recruitment and tumor angiogenesis was 
showed for lupeol and stigmasterol in an in vivo model [46].
2.2 Alkaloids
Treatment with 9-hydroxycanthin-6-one, a β-carboline alkaloid isolated from 
the Ailanthus altissima stem bark, inhibited the levels of M2 phenotype markers 
and some cancer-promoting factors, such as MMP-2, MMP-9 and VEGF, in mac-
rophages educated in ovarian cancer–conditioned medium. The compound also 
decreased the expressions of MCP-1 and RANTES, major determinants of macro-
phage recruitment at tumor sites, in ovarian cancer cells [47].
A regulatory effect on macrophage differentiation during tumor development 
exerts phlenumdines E, A, hupermine A and 12-epi-lycopodine-N-oxide isolated 
from the club moss Phlegmariurus nummulariifolius (Blume) Ching, which exhibited 
an inhibitory effect on IL-10–induced expression of CD163, an M2 phenotype 
marker, in HMDMs [48].
Sophoridine, a bioactive alkaloid extracted from the seeds of Sophora alo-
pecuroides L, was able to reshape gastric cancer immune microenvironment by 
shifting TAM polarization to M1 and suppressing M2-TAM polarization through 
TLR4/IRF3 axis [49].
2.3 Phenolic compounds
2.3.1 Chalcones
In a model of azoxymethane (AOM)/dextran sodium sulfate (DSS)-induced 
colitis-associated tumorigenesis, it was showed that isoliquiritigenin (6′-deoxychal-
cone) inhibits M2 macrophage polarization depending on the downregulation of the 
IL-6/STAT3 pathway [50]. The same mechanism was proposed by Sumiyoshi et al. 
[51], for xanthoangelol and 4-hydroxyderricin, chalcones isolated from Angelica 
keiskei roots. In the in vivo study, the antitumor action of xanthoangelol was higher 
than that of 4-hydroxyderricin and it was proposed that the presence of a 4-free phe-
nolic OH and/or the presence of a longer isoprene moiety in C-3 could be the cause 
of better activity of xanthoangelol. Reducing breast cancer cells’ migration with the 
aid of M2 macrophages was achieved in vitro by the total flavonoid from Glycyrrhizae 
Radix et Rhizoma and isoliquiritigenin. These compounds inhibited gene and protein 
expression of Arg-1, upregulated gene of HO-1 and protein expression of iNOS, and 
enhanced the expression of microRNA 155 and its target gene SHIP1 [52].
2.3.2 Catechins
Macrophage infiltration and differentiation of macrophages into tumor-
promoting M2 macrophage were decreased by epigallocatechin gallate (EGCG) 
treatment in murine tumor models and the molecular mechanism proposed was 
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the downregulation of NF-κB pathway [53, 54]. EGCG can be rapidly degraded in 
vivo limiting its clinical application. A peracetate-protected EGCG (Pro-EGCG) 
synthesized by modification of the reactive hydroxyl groups with peracetate groups 
proved six times more stability than EGCG and showed greater efficacy in induction 
of cell death in leukemic cells. Treatment with Pro-EGCG inhibits differentiation of 
macrophages toward TAMs through decreasing CXCL12 expression in endometrial 
stromal cells with no influence on the expression level of CD163 and CD206 [55].
2.3.3 Flavonoids
Luteolin, 3 0,4 0,5,7-tetrahydroxyflavone, is a common flavonoid derived from 
various plants and inhibits IL-4–induced phosphorylation of STAT6 and the TAM 
phenotype, ameliorating the recruitment of monocytes and the migration of lung 
cancer cells by the reduction of chemokine CCL2 secretion from macrophages [56]. 
The antitumor mechanism of luteolin in non-small cell lung carcinoma (NSCLC) 
was mediated by downregulation of TAM receptor tyrosine kinases (RTKs), and it 
was found to decrease the protein levels of all three TAM RTKs in the A549 and A549/
CisR cells in a dose-dependent manner [57]. In an in vitro tumor model, cobalt chlo-
ride (CoCl2) was used to simulate hypoxia and it was showed that luteolin decreased 
the expression of VEGF and MMP-9, which promote angiogenesis. In addition, luteo-
lin also suppressed the activation of HIF-1 and phosphorylated-signal transducer and 
activator of STAT3 signaling, particularly within the M2-like TAMs [58].
The regulation of M2 macrophage repolarization through inhibiting PI3K/Akt 
signal pathway is the mechanism proposed for baicalein (5,6,7-trihydroxyflavone), a 
widely used Chinese herbal medicine derived from the root of Scutellaria baicalensis. 
Changing the phenotype of macrophages from M2 to M1 was supported by decreas-
ing of M2-specific marker CD206 correlated to the increased M1-specific marker 
CD86. Still, the authors of the study suggested that the cytotoxic effect of baicalein 
on breast cancer cells directly is more pronounced than on TAMs (IC 50 of baicalein 
for MDA-MB-231 at 24 h, 48 h and 72 h was 79.12/50.10/34.77 μmol/L, for MCF-7 
at 24 h, 48 h and 72 h was 49.76/43.73/39.44 μmol/L, for TAM at 24 h, 48 h and 72 h 
was 191.5/107.1/41.78 μmol/L, respectively) [59].
It has been reported that a novel chrysin (5,7-dihydroxyflavone) analog 
8-bromo-7-methoxychrysin has anticancer activities with more potent bioactiv-
ity than the lead compound [60]. It also has the capacity to regulate the tumor 
microenvironment by inhibition of NF-κB activation, suppressing significantly 
the expression of the M2 macrophage marker CD163 and modulating the secretion 
profile of TAM cytokines [61].
According to traditional Chinese medicine (TCM) theory, herbs with 
Qi-tonifying character are involved in improving the defense capacity of immune 
system. Total flavonoids from Glycyrrhizae Radix et Rhizoma significantly inhibited 
the expression of Arg-1 (above 90% at 100 μg/mL), one of the phenotype markers 
of M2 macrophages, and suppressed M2 polarization of macrophages partly by 
inactivating STAT6 pathway. The regulation of M1 and M2 markers’ expressions 
was partly due to the enhancement of miR-155 levels [62].
Naringin (4′,5,7 trihydroxyflavanone-7-rhamnoglucoside) exert a potential 
inhibitory effect on tumor progression by inducing CD169-positive and M1-like 
macrophages, potentially correlating with cytotoxic T-cell activation [63].
2.3.4 Isoflavones
Puerarin [4H-1-benzopyran-4-one, 8-β-d-glucopyranosyl-7-hydroxy-3-
(4-hydroxyphenyl)] is the major bioactive ingredient isolated from the root of 
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traditional Chinese medicine Ge-gen (Radix Puerariae) able to suppress the cell 
invasion and migration probably through inactivating MEK/ERK 1/2 pathway in a 
model of NSCLC. Also, it was showed that puerarin acts directly on macrophages by 
increasing M1 macrophage markers (CD197+, iNOS+ and CD40+) and reducing the 
expression of M2 markers (CD206+, Arg-1+ and CD163+) [64].
Another isoflavone, genistein, can inhibit the increased M2 polarization of mac-
rophages and stemness of ovarian cancer cells by co-culture of macrophages with 
ovarian cancer stem-like cells through disrupting IL-8/STAT3 signaling axis [65].
2.3.5 Phenolic acids
Chlorogenic acid (5-caffeoylquinic acid, CA), the ester of caffeic acid, is a phe-
nolic compound widely found in plants. It was showed that this compound inhibits 
growth of G422 glioma in vivo, an effect associated with a decrease of M2-like TAMs 
and recruitment of M1-like TAMs into tumor tissue. Low dose (1 μM) of CA could 
significantly inhibit the M2 macrophage-induced proliferation of glioma and breast 
cancer cells, mainly via STAT1 and STAT6 signaling pathways [66]. Oršolić et al. 
[67] concluded that the antitumor activity of CA is the result of the synergistic 
activities of different mechanisms by which CA acts on proliferation, angiogenesis, 
immunomodulation and survival. Mice with Ehrlich ascites tumor (EAT) and 
treated for 10 days with CA in a dose of 40 and/or 80 mg kg−1 showed an increase 
of the cytotoxic actions of M1 macrophages and inhibition of the tumor growth, 
probably mediated through its antioxidative activity.
2.3.6 Lignans
Deoxyschizandrin, a major dibenzocyclooctadiene lignan present in Schisandra 
chinensis berries, significantly suppressed CD163 and CD209 expression, inhibiting 
protumor mediator production as well as M2 polarization in TAM macrophages 
stimulated by the conditioned medium of A2780 cells [68].
2.3.7 Other phenolic compounds
Several studies focused on a stilbene derivative, resveratrol (3,4′,5-trihy-
droxystilbene), a widely studied compound that exhibits potent preventive 
effects on lifestyle-related disorders such as hyperlipidemia, obesity, coronary 
heart disease and cancer, as well as on aging. In lung cancer tumors, resveratrol 
induced their sluggish growth by decreasing F4/80 positive expressing cells and 
M2 polarization (lower expression of M2 markers-IL-10, Arg-1 and CD206), 
probably by STAT3 suppression [69]. Antitumor and antimetastatic effects of 
resveratrol (25 and 50 μM) based on the regulation of M2 macrophage activation 
and differentiation were confirmed by Kimura and Sumiyoshi [70], which also 
conducted a study for correlation of stilbene structure with biological activ-
ity. Among the nine stilbenes examined, 2,3-,3,4-, and 4,4′-dihydroxystilbene 
inhibited the production of MCP-1 in M2-polarized THP-1 macrophages at a 
concentration of 50 μM, demonstrating that the inhibitory effects of stilbenes 
with dihydroxy groups on the production of MCP-1 were greater than those with 
mono-hydroxyl groups. Dihydroxystilbene at 25 and 50 μM, 3,4-dihydroxys-
tilbene at 50 μM, and 4,4′-dihydroxystilbene at 10, 25 and 50 μM significantly 
inhibited the production of IL-10 by M2 THP-1 macrophages. The three dihy-
droxystilbenes, 2,3-, 3,4-, and 4,4′-dihydroxystilbenes, at concentrations of 
10–50 μM inhibited p-STAT3 increase during M2 THP-1 macrophage differentia-
tion induced by IL-4 plus IL-13 [71].
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The resveratrol analogue, HS-1793 (4-(6-hydroxy-2-naphthyl)-1,3-benzene-
diol), was also shown to elevate the level of IFN-γ production conducting repro-
graming of TAMs M2 phenotype [72].
Curcumin ((1E,6E)-1,7-Bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-
3,5-dione), a natural phenol and the main active ingredient in turmeric, acts in 
several ways as a suppressor of macrophage functions. Even though curcumin has 
previously received considerable attention from researchers as an anti-inflamma-
tory agent, it has a promising future in the area of immunomodulation [73]. Most 
of the studies on curcumin focused on the anti-inflammatory effect, promoting 
the conversion of macrophages from M1  to an anti-inflammatory and protective 
M2 phenotype [73]. Gao et al. [74] demonstrated that curcumin plays a key role in 
M2 polarization in two ways: (1) via the inhibition of DNA methyltransferase3b 
(DNMT3b), overexpression of which can promote increased M1 polarization, and 
(2) via increased phosphorylation of signal transducer and activator of transcrip-
tion STAT-6, an important transcription factor activated by IL-4 and IL-10. Other 
studies showed that curcumin also induces TAMs re-polarization from tumor-pro-
moting M2 phenotype toward the more antitumor M1 phenotype in tumor-bearing 
hosts, mediated by inhibition of STAT3 activity [75]. Curcumin administration and 
delivery to glioblastoma brain tumors (GBM) caused a dramatic re-polarization 
of TAMs from an M2 to M1 phenotype and tumor remission in 50–60% of GBM-
bearing mice [76]. Hydrazinocurcumin, a synthetic analog of curcumin encapsu-
lated within nanoparticles, reeducates TAMs to an M1-like phenotype IL-10 low 
IL-12 high TGF-β low [54].
It was showed that TriCurin, a synergistic formulation of curcumin, resvera-
trol, and epicatechin gallate (molar ratio C:E:R: 4:1:12.5) can shift TAM polarity in 
HPV-positive HNSCC by silencing the M2 TAM and activating/recruiting a discrete 
population of M1 TAM while maintaining a constant number of overall intra-tumor 
Iba1+ TAM, along with expression of activated STAT3 and induction of activated 
STAT1 and NF-kB (p65) [77]. Moreover, a liposomal formulation of TriCurin with 
increased bioavailability (TrLp) was able to cause repolarization of M2-like tumor 
(GBM)-associated microglia/macrophages to the tumoricidal M1-like phenotype 
and intra-GBM recruitment of activated natural killer cells [78].
In a urethane-induced lung carcinogenic model, lung carcinogenesis was 
ameliorated with increased M1 macrophages and decreased M2 macrophages in the 
lung interstitial by administration of 6-gingerol ((S)-5-hydroxy-1-(4-hydroxy-3-
methoxyphenyl)-3-decanone), the main bioactive component in ginger (Zingiber 
officinale Roscoe). M2 macrophage-resetting efficacy of 6-gingerol was confirmed 
in a Lewis lung cancer allograft model and the mechanism proposed was the reduc-
tion of Arg-1 and ROS levels and elevation of L-arginine and NO levels [79].
Also, it was showed that paeoniflorin, one of the major active constituents of 
Paeonia lactiflora Pallas, inhibits the alternative activation of macrophages in subcu-
taneous xenograft tumors of the C57BL/6 J mice at doses of 40 and 20 mg·kg−1 [80].
2.4 Polysaccharides
It was suggested that modulation of TAM polarization was implicated in the 
antitumor immunostimulatory activity of polysaccharides from Panax japonicus 
(ginseng). The transcription and production of TGF-β and IL-10, two well-known 
immunosuppressive cytokines secreted by TAMs, were reduced in response to 
Panax polysaccharides and also the number of infiltrated CD168+ M2 TAMs was 
substantially declined although the number of CD68+ total macrophages in trans-
planted tumor tissues remained almost unchanged [81]. A significant inhibition 
of Arg-1 expression (above 90% at 100 μg/mL), one of the phenotype markers of 
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M2 macrophages, was also observed for the ethanol extract of Ginseng Radix et 
Rhizoma [62]. Recently, Chen et al. [82], showed that water extract of Ginseng and 
Astragalus could be a novel option for integrative cancer therapies due mainly to 
their ability to regulate macrophage polarization.
In a murine model of sarcoma, immunotherapy with IAPS-2 (acidic polysac-
charide, namely IAPS-2, from the root of Ilex asprella) demonstrated that it could 
significantly inhibit the growth of tumors via modulating the function of TAMs 
and increase the animal survival rate [83]. Similar results were obtained with an 
aqueous extract of Trametes robiniophila Murr (Huaier), a sandy beige mushroom 
found on the truck of trees and has been widely used in TCM for approximately 
1600 years for its antitumor, antiangiogenic and immunomodulatory effects. 
Huaier not only modulates the macrophage polarization but also could inhibit the 
macrophage-induced angiogenesis by decreasing the expression of VEGF, MMP2 
and MMP9, thus inhibiting the formation of new blood vessels in tumor [84].
2.5 Coumarins
Esculetin (6,7-dihydroxycoumarin) and fraxetin (6-methoxy-7,8-dihydroxy-
coumarin) (50, 75 and 100 μM) inhibited the production of IL-10, MCP-1 and 
TGF-β-1 in macrophages and the phosphorylation of STAT 3 without affecting 
its expression during the differentiation of M2 macrophages. Esculetin also 
suppressed the increased production of these cytokines during M2 macrophage 
differentiation at 10–100 μM. On the other hand, daphentin (7,8-dihydroxycou-
marin) had no such effects, revealing that coumarins with two hydroxyl groups at 
the 6 and 7 positions (esculetin) or coumarins with a methoxy group at the 6 and 
two hydroxyl groups at the 7 and 8 positions (fraxetin) are more active, exhibiting 
antitumor and antimetastatic actions in osteosarcoma LM8 cells [85]. The antitu-
mor and antimetastatic actions of esculetin may be due to the dual actions at tumor 
and TAM sites: inhibition of the expression of cyclin D 1 and CDK4 in osteosar-
coma LM8 cells, and also decreasing the STAT 3 phosphorylation in macrophages. 
In the case of fraxetin, the effects are partly attributed to the inhibition of M2 
macrophage differentiation [85].
A classical formula of traditional Chinese medicine (TCM) to alleviate lung can-
cer–related symptoms is Bu-Fei decoction (BFD), consisting of six herbal Chinese 
medicines-Codonopsis pilosula, Schisandra chinensis, Rehmannia glutinosa, Astragalus 
sp., Aster sp. and Morus sp.-but it has not been established whether it induces an 
antitumor effect or it modulates the tumor microenvironment. The result of an 
in vivo study revealed that BFD successfully interrupted the interaction between 
tumor cells and TAMs by inhibiting the expression of two important markers: IL-10 
(correlated with late stage (stage II, III and IV), lymph node metastases, pleural 
invasion, lymphovascular invasion and poor differentiation in NSCLC patients) 
and PD-L1 (correlated with poor prognosis in a number of human cancers, includ-
ing breast cancer, kidney cancer and NSCLCs) [86].
2.6 Anthraquinones
It has been shown that emodin (6-methyl-1,3,8-trihydroxyanthraquinone), the 
active ingredient of several Chinese herbs including Rhubarb (Rheum palmatum), 
inhibits the growth of a variety of tumors and enhances the responsiveness of tumors 
to chemotherapy agents. In breast cancer, emodin directly inhibited macrophage 
infiltration and M2 polarization in the tumors, independent of tumor size [87]. 
Previously, Jia et al. [88], showed that emodin is not cytotoxic to breast cancer cells 
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at concentration achieved in vivo (up to 30 μM) and it failed to affect macrophage 
infiltration in primary tumors. In contrast to its lack of effects on primary tumors, 
emodin dramatically suppressed lung metastasis by diminishing phosphorylation of 
STAT6 and C/EBPβ signaling upon IL-4 stimulation [88]. Further, it was showed that 
emodin suppresses the activation of multiple signaling pathways, including NF-kB, 
IRF5, MAPK, STAT1 or STAT6, and IRF4, depending on the environmental settings. 
It acts mostly on M2 polarization, suggesting that emodin could be most beneficial 
for patients with M2 macrophage-driven diseases [89].
2.7 Other herbal compounds/preparations
In oral squamous cell carcinoma (OSCC) animal models, highly pure super 
critical CO2 leaf extract of Azadirachta indica (Neem) induces an M1 phenotype 
in TAMs in vivo, and the primary active component, nimbolide (a limonoid tetra-
nortriterpenoid with an α,β-unsaturated ketone system and a δ-lactone ring) has 
significant anticancer activity in established OSCC xenografts [90]. β-Elemene, a 
widely known sesquiterpene, regulated the polarization of macrophages from M2 
to M1, inhibiting the proliferation, migration and invasion of lung cancer cells and 
enhancing its radiosensitivity [91].
Onionin A (ONA), a natural low molecular weight compound containing sulfur 
isolated from onions, inhibited the EOC cell-induced M2 polarization of HMDMs, and 
STAT3 activation was significantly inhibited by ONA treatment in all cell lines [92].
Adjunctive treatment with Withaferin A, the most abundant constituent of 
Withania somnifera (Ashwagandha) root extract, reduced myeloid cell-mediated 
immune suppression and polarized immunity toward a tumor-rejecting type 1 
phenotype, facilitating the development of antitumor immunity [93].
Traditional Chinese medicine provides pharmacologically efficient preparates 
such as KSG-002, a hydroalcoholic extract of radices Astragalus membranaceus 
and Angelica gigas at 3:  1 ratio that suppresses breast cancer growth and metasta-
sis through targeting NF-κB–mediated TNF α production in macrophages [94] 
and SH003, mixed extract from Astragalus membranaceus, Angelica gigas and 
Trichosanthes kirilowii Maximowicz that suppresses highly metastatic breast cancer 
growth and metastasis by inhibiting STAT3-IL-6 signaling path [95].
Traditional Chinese medicine Jianpi Yangzheng Decoction (JPYZ) used for 
improving the quality of life and prolonging the survival of gastric cancer patients 
was more effective compared with Jianpi Yangzheng Xiaozheng Decoction 
(JPYZXZ) for inducing the phenotypic change in macrophages from M2 to M1. 
JPYZXZ inhibits the gastric cancer EMT more effectively than JPYZ, but JPYZ 
primarily works to regulate the phenotypic change in macrophages from M2 to 
M1 [96].
CXCL-1 was also found to be a cytokine secreted by tumor-associated macro-
phage, which recruits myeloid-derived suppressor cells to form pre-metastatic niche 
and led to liver metastasis from colorectal cancer. The current study demonstrated 
that after administration of XIAOPI formula (consisting of 10 herbs including 
Epimedium brevicornum, Cistanche deserticola, Leonurus heterophyllus, Salvia miltior-
rhiza, Curcuma aromatica, Rhizoma Curcumae, Ligustrum lucidum, Radix Polygoni 
Multiflori preparata, Crassostrea gigas and Carapax trionycis), the density of TAMs 
decreased significantly and the level of CXCL-1 was also inhibited in both mouse 
plasma and cellular supernatants. When CXCL-1 cytokine was co-administrated 
with XIAOPI formula, the antimetastatic property of XIAOPI formula was blocked, 
indicating that CXCL-1 might be the principal gene involved in the network regu-
lating the action of XIAOPI formula [97].
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3. Conclusions
Macrophages, as key players in the tumor microenvironment, play essential roles 
in maintenance and progression of malignant state. Due to their plasticity, these 
cells balance between pro- and antitumoral effects in close correlation to specific 
factors. Recent immunotherapeutic strategies focus on tumor-associated macro-
phages in two main directions: to inhibit protumor macrophages and their suppres-
sive effects (CCL2 inhibitors, trabectedin, zoledronic acid, JAK/STAT inhibitors, 
etc.) and to activate TAMs to an antitumor phenotype (TLR and CD40 agonists, 
PI3kδ inhibitor, VEGF and Ang2 inhibitors, etc.).
Several natural compounds/herbal extracts were studied as therapeutic/sup-
portive agents for macrophage modulation in different types of cancers, most 
of them being able to change M2 polarization (protumoral) to M1 polarization 
(antitumoral). They belong to various classes of herbal compounds: saponins 
(corosolic and oleanolic acids, astragaloside, ginsenosides, celastrol, etc.), alka-
loids (9-hydroxycanthin-6-one, phlenumdines E, A, hupermine A and 12-epi-
lycopodine-N-oxide, sophoridine, etc.), flavonoids and polyphenolcarboxylic 
acids (isoliquiritigenin, xanthoangelol and 4-hydroxyderricin, baicalein, naringin, 
genistein, deoxyschizandrin, chlorogenic acid, curcumin, 6-gingerol and paeoniflo-
rin), polysaccharides (isolated from various vegetal sources), coumarins (esculetin, 
fraxetin, etc.), and anthraquinones (emodin). This action is most probably achieved 
by downregulation of the STAT3, STAT 6 and NF-kB pathways with consecutive 
modulation of the secretory profile of TAM cytokines.
TCM supports the dual approach of cancer therapy, to destroy cancer cells on 
one hand and to improve patients’ immunological status on the other hand. For 
several preparations such as Jianpi Yangzheng Decoction, Bu-Fei decoction and 
XIAOPI formula, research studies proved the correlation between cancer cells and 
tumor microenvironment and the effective intervention of these herbal products in 
delaying/breaking the tumorigenic process.
Low solubility of some herbal compounds limits their clinical application and 
it conducted to designing of new analogs with improved bioavailability-ginseng-
derived nanoparticles, peracetate-protected EGCG, chrysin and resveratrol analogs.
By now, many herbal compounds have been shown to exhibit antitumor effects 
in various cancer types. Further, more researches need to be focused on the influ-
ence of these valuable compounds/preparations on modulation of the tumor 
microenvironment, as key element in the relation of tumor-host.
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